PHIO Margin dodolan resik Phio Pharmaceuticals Corp.

Logo perusahaan publik Phio Pharmaceuticals Corp. (PHIO)

The net margin efficiency of Phio Pharmaceuticals, as presented by the GURU.Markets platform, demonstrates the resilience of a model where 0.00 is the current value of the indicator. Phio Pharmaceuticals is developing RNA interference via the INTASYL platform, creating exclusive treatment protocols. The team brings together leading cancer geneticists who possess academic freedom. The technology stack is supplemented by robotic molecule screening and predictive software.

PHIO: Margin dodolan resik Phio Pharmaceuticals Corp 04.07.2022 - 19.11.2026

Ringkesan rincian data analitis phiopharma.com (PHIO)

- rega saham lan prakiraan rega para ahli:
Analisis dhasar perusahaan:RXi Pharmaceuticals - PHIO
Barang unggulan Phio Pharmaceuticals

Net margin is calculated as the ratio of net profit to total revenue. This coefficient measures cost management efficiency and the fundamental profitability of each unit of sales. For Phio Pharmaceuticals (PHIO), this metric reflects the development costs of the INTASYL RNA interference platform within the context of immuno-oncology. The trend in annual net margin allows investors to filter out speculative noise from real growth in operational efficiency. The trajectory of the annual net margin determines the balance between potential returns and the risk of overpayment.

Analisis pesaing

TEM: Margin dodolan resik|Tingkat bathi miturut bathi resik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Margin dodolan resik|Repligen Inc. - Margin bathi resik|Margin dodolan resik RNA|CRSP - Margin resik|GeneDx - Rentabilitas dodolan miturut bathi resik|Tingkat bathi resik RARE|Beam Tx - Margin dodolan resik|SRPT - Margin dodolan resik|TWST (Twist Bio) - Rentabilitas dodolan miturut bathi resik|Rentabilitas dodolan resik TXG|Rentabilitas dodolan miturut bathi resik NTLA|Stoke Therapeutics Inc (STOK) - Margin dodolan perusahaan|Margin dodolan resik BLFS|Margin resik WVE (Wave Life Sciences Corp)|Margin resik Maze Therapeutics MAZE|Tingkat bathi resik SION|PRME - Margin resik|Margin dodolan perusahaan Taysha TSHA|QURE: Margin dodolan resik|Rentabilitas dodolan miturut bathi resik MeiraGTx PLC|RGNX (REGENXBIO Inc) - Margin dodolan resik|solidbio.com (SLDB) - Margin dodolan perusahaan|Margin resik Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Rentabilitas dodolan resik|Benitec Biopharma - Rentabilitas dodolan miturut bathi resik|DSGN: Rentabilitas dodolan resik|RCKT: Rentabilitas dodolan miturut bathi resik|FDMT - Margin dodolan resik|LXEO: Margin dodolan resik|Korro Bio Inc. - Tingkat bathi resik|EDIT (editasmedicine.com) - Margin dodolan resik|Margin resik SLN|Margin resik ProQR Therapeutics NV (PRQR)|Codexis - Rentabilitas dodolan resik|Margin resik Sangamo SGMO|NAUT: Rentabilitas dodolan resik|MGX: Rentabilitas dodolan miturut bathi resik|Margin resik Precision BioSciences|GBIO (generationbio.com) - Rentabilitas dodolan miturut bathi resik|Margin resik boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Margin dodolan resik|Rentabilitas dodolan resik IMNN (Imunon, Inc.)|Margin resik Mustang Bio, Inc. (MBIO)|Margin dodolan perusahaan TransCode Therapeutics, Inc.|Margin resik Bionano Genomics BNGO|Tingkat bathi resik APDN|BLUE - Margin resik|Margin bathi resik IPA|Omega Therapeutics, Inc. (OMGA) - Margin resik|Singular Genomics Corp (OMIC) - Margin dodolan resik|RGLS (Regulus Therapeutics, Inc.) - Margin dodolan resik|SYRS: Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik TBIO (Telesis Bio Inc.)|Margin dodolan resik TRACON Pharmaceuticals Inc. (TCON)|Margin resik Unity Bio UBX